CORPORATE AND COMMERCIAL
LEGAL SERVICES
FOR LIFE SCIENCE COMPANIES
WWW.PHARMATECHLAW.COM
DIMITRIOS J. ANGELIS, JD
**@*************.***
Practice Focus:
Dimitrios has spent his career both on the “legal side” as a General Counsel at several life science companies, and on the “business side” as a CEO of a public company listed on NASDAQ, thereby allowing him the breadth of experience to better understand the value of sound legal advice and the interplay to good business judgment.
The majority of Dimitrios’ time has been in the life sciences advising on a broad spectrum of matters. This includes drafting a broad range of contracts, negotiations, cross-border transactions, mergers and acquisitions, securities law, global patent strategy, litigation strategy, compliance, employment law, initial public offerings, private placements, and real estate. Dimitrios has also overseen the Human Resources function and conducted several confidential HR investigations, and has run complex international licensing arrangements. Dimitrios has advised clients at every stage of their development including the start-up stage, raising private and public capital, doing fundraising roadshows, the IPO, managing investor relations, preparing for a company sale, as well as merging two public companies. Dimitrios currently sits on three public company boards and advises clients in ways that highlight the culmination of his broad legal experiences and his unique executive officer posts. Common sense, good judgment and the ability to negotiate exceptionally well exemplify the valuable advice Dimitrios gives. Education:
2001 J.D. NYU School of Law
(Corporate Law)
1994 MA California State University
(Negotiations)
1992 BA Boston College
(Philosophy/ English)
Bar Admissions:
New York
New Jersey
Selected Presentations:
American Conference Institute, New York, NY Speaker on: “Effective Use of Outside Counsel”
U.S. Law Conference, Washington, D.C., Speaker on:
“Effective International Litigation Strategy”
International Bar Association Conference, Dallas, Texas, Speaker on: “Patents and Intellectual Property Due Diligence”
Current and Previous Positions:
2019 to Date Pharma Tech Law LLC
Partner
2015 to 2018 Life Science Legal LLC
Principal
2014 to 2015 OTI America
CEO and Chairman of the Board
2012 to 2014 Wockhardt Pharmaceuticals
General Counsel
2008 to 2012 Dr. Reddy’s Laboratories
US Head Counsel
2007 to 2008 Osteotech Inc., General Counsel
2004 to 2007 Actavis Inc., Commercial Counsel
2001 to 2004 Mayer Brown, Corporate Associate
Other Positions:
Digirad Corp., Board Member (NASDAQ: DRAD)
The One Group, Board Member (NASDAQ: STKS)
Ameri100 Inc, Board Member (NASDAQ: AMRH)